Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies

Anna Makowska, Udo Kontny · 2026

Read Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies by Anna Makowska, Udo Kontny (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13204310.txt.

Description

Anna Makowska and Udo Kontny review natural killer cells as a cancer treatment platform in this 2026 paper. These immune cells kill without needing a prior lesson about their target, and they carry a gentler side-effect profile than engineered T cells. The review gives special weight to nasopharyngeal carcinoma, a virus-driven throat cancer.

The authors survey the whole pipeline: cytokine support, donated cell products, engager molecules that lash the cells to tumors, and receptor-armed versions. Trials, mostly in blood cancers, show the approach is safe and active. Weak points remain: the cells fade fast, home poorly, and tumors learn to hide. The throat cancer setting shows both the blocks and the openings clearly.

Catalog record

CREATORAnna Makowska, Udo Kontny
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13204310

Browse the full library · About the Tower of Babel